Hattori, M., Hattori, N., Nakayama, G., Umeda, S., Kishida, T., Kawase, Y., Ezaka, K., Tsutsuyama, M., Sakai, M., Ito, T., Yanbe, Y., Kanda, M., Tanaka, C., Murotani, K., Ando, M., Kodera, Y. (2025). Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.124